Skip to content
Study details
Enrolling now

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Jacques E. Chelly
NCT IDNCT05506878ClinicalTrials.gov data as of Apr 2026
Target enrollment

286

Study length

about 3.9 years

Ages

18+

Locations

4 sites in PA

What this study is about

Researchers are testing if auriculotherapy, a treatment involving nerve stimulation of the ear, can reduce the need for opioid pain medication after surgery. The trial will involve adults undergoing abdominal or pelvic surgery and randomly assigning them to either receive the auriculotherapy device (NSS-2 BRIDGE) or a placebo device.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use NSS-2 BRIDGE
  • 2.Use Sham NSS-2 BRIDGE

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Opioid Consumption

Secondary: Area under the curve of post-operative pain rating using a numerical rating scale, Change in post-operative pain rating using the Pain Catastrophizing Scale, Change in the Brief Symptom Index Somatization Scale, Device tolerability, Length of hospital stay, Post-operative pain rating using a numerical rating scale, Pre-operative Brief Symptom Index Somatization Scale, Pre-operative pain rating using the Pain Catastrophizing Scale

Body systems

Oncology, Psychiatry / Mental Health, Gastroenterology